Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 AngioDynamicsIntersect ENTSurmodicsOraSure TechnologiesOrthofix Medical
SymbolNASDAQ:ANGONASDAQ:XENTNASDAQ:SRDXNASDAQ:OSURNASDAQ:OFIX
Price Information
Current Price$24.23$19.98$58.19$10.01$44.17
52 Week RangeBuyHoldBuyBuyHold
MarketRank™
Overall Score1.41.71.31.71.2
Analysis Score1.33.22.53.31.0
Community Score2.22.82.52.82.3
Dividend Score0.00.00.00.00.0
Ownership Score1.71.71.71.71.7
Earnings & Valuation Score1.90.60.00.61.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$24.00$25.67$69.00$17.50$39.00
% Upside from Price Target-0.95% downside28.46% upside18.58% upside74.83% upside-11.70% downside
Trade Information
Market Cap$924.06 million$659.66 million$800.46 million$720.18 million$861.85 million
Beta0.891.3410.041.12
Average Volume350,781207,06253,7081,094,79992,713
Sales & Book Value
Annual Revenue$264.16 million$109.14 million$94.86 million$154.60 million$459.95 million
Price / Sales3.506.048.444.661.87
Cashflow$0.98 per shareN/A$0.86 per share$0.20 per share$2.95 per share
Price / Cash24.78N/A67.6450.7814.95
Book Value$12.09 per share$3.75 per share$9.63 per share$4.98 per share$17.22 per share
Price / Book2.005.336.042.012.57
Profitability
Net Income$-166,790,000.00$-42,990,000.00$1.12 million$16.66 million$-28,460,000.00
EPS$0.09($1.37)$0.13$0.13$1.47
Trailing P/E RatioN/AN/A727.38N/A36.81
Forward P/E Ratio134.61N/A∞11.1252.58
P/E GrowthN/AN/A12.89N/A24.35
Net Margins-62.82%-71.96%1.18%-9.05%5.75%
Return on Equity (ROE)-0.12%-55.81%1.42%-3.51%1.82%
Return on Assets (ROA)-0.10%-40.23%1.12%-3.13%1.20%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.09%0.72%N/AN/A0.06%
Current Ratio3.27%11.28%4.58%8.14%2.73%
Quick Ratio2.19%10.29%4.27%7.32%1.84%
Ownership Information
Institutional Ownership Percentage94.86%84.32%87.19%98.13%93.85%
Insider Ownership Percentage3.80%3.50%7.10%1.70%3.50%
Miscellaneous
Employees8004063705701,036
Shares Outstanding38.14 million33.02 million13.76 million71.95 million19.51 million
Next Earnings Date7/15/2021 (Estimated)5/10/2021 (Estimated)5/5/2021 (Estimated)5/5/2021 (Estimated)5/14/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Orthofix Medical Inc. (NASDAQ:OFIX) Expected to Post Quarterly Sales of $95.40 MillionOrthofix Medical Inc. (NASDAQ:OFIX) Expected to Post Quarterly Sales of $95.40 Million
americanbankingnews.com - April 17 at 1:42 AM
Analysts Anticipate Orthofix Medical Inc. (NASDAQ:OFIX) Will Announce Earnings of $0.07 Per Share Analysts Anticipate Orthofix Medical Inc. (NASDAQ:OFIX) Will Announce Earnings of $0.07 Per Share
americanbankingnews.com - April 15 at 6:20 PM
Orthofix Medical (NASDAQ:OFIX) Shares Gap Up to $42.05Orthofix Medical (NASDAQ:OFIX) Shares Gap Up to $42.05
americanbankingnews.com - April 14 at 11:32 AM
Orthofix board chair to step down after 7 yearsOrthofix board chair to step down after 7 years
beckersspine.com - April 7 at 5:12 PM
Orthofix Announces Board Chair TransitionOrthofix Announces Board Chair Transition
finance.yahoo.com - April 7 at 7:11 AM
Orthofix (OFIX) Wins FDA Clearance for CONSTRUX Mini Ti SystemOrthofix (OFIX) Wins FDA Clearance for CONSTRUX Mini Ti System
finance.yahoo.com - April 6 at 10:36 AM
Orthofix wins approval for 3D-printed cervical spine implantOrthofix wins approval for 3D-printed cervical spine implant
beckersspine.com - April 5 at 12:29 PM
FDA clears Orthofix 3D-printed titanium cervical spacer systemFDA clears Orthofix 3D-printed titanium cervical spacer system
massdevice.com - April 5 at 12:29 PM
Global Minimally Invasive Surgery Market - Top Participant To Focus On Regional ExpansionGlobal Minimally Invasive Surgery Market - Top Participant To Focus On Regional Expansion
openpr.com - April 5 at 7:24 AM
Orthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate TechnologyOrthofix Announces FDA Clearance and Initial Patient Implant of the Company’s First 3D-Printed Titanium Cervical Spacer System with Nanovate Technology
finance.yahoo.com - April 5 at 7:24 AM
Analysts Anticipate Orthofix Medical Inc. (NASDAQ:OFIX) Will Post Quarterly Sales of $95.40 Million Analysts Anticipate Orthofix Medical Inc. (NASDAQ:OFIX) Will Post Quarterly Sales of $95.40 Million
americanbankingnews.com - March 31 at 1:30 PM
Orthofix Medical Inc. (NASDAQ:OFIX) Expected to Post Earnings of $0.07 Per ShareOrthofix Medical Inc. (NASDAQ:OFIX) Expected to Post Earnings of $0.07 Per Share
americanbankingnews.com - March 29 at 4:50 AM
Impact Of Covid-19 On Spinal Devices Market Demand…Impact Of Covid-19 On Spinal Devices Market Demand…
pharmiweb.com - March 19 at 5:27 PM
Trauma Products Market Share, Size, Trends, Industry Analysis to 2027 by Disease Type; By Technology; By Specialty; By End-Use; By RegionsTrauma Products Market Share, Size, Trends, Industry Analysis to 2027 by Disease Type; By Technology; By Specialty; By End-Use; By Regions
marketwatch.com - March 16 at 5:36 PM
Orthofix Medical Inc.s (NASDAQ:OFIX) Intrinsic Value Is Potentially 18% Below Its Share PriceOrthofix Medical Inc.'s (NASDAQ:OFIX) Intrinsic Value Is Potentially 18% Below Its Share Price
finance.yahoo.com - March 9 at 1:16 PM
Global Orthobiologics Market (2021 to 2029) - Featuring Arthrex, Bioventus and Medtronic Among OthersGlobal Orthobiologics Market (2021 to 2029) - Featuring Arthrex, Bioventus and Medtronic Among Others
finance.yahoo.com - March 5 at 7:38 AM
Medical Implants Market By Application Analysis, Regional Outlook, Competitive Strategies And Forecast 2020 - 2027 by ARCMedical Implants Market By Application Analysis, Regional Outlook, Competitive Strategies And Forecast 2020 - 2027 by ARC
marketwatch.com - March 2 at 8:24 AM
Orthofix Medical Inc. (OFIX) CEO Jon Serbousek on Q4 2020 Results - Earnings Call TranscriptOrthofix Medical Inc. (OFIX) CEO Jon Serbousek on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 28 at 8:29 AM
Orthofix Reports Fourth Quarter and Fiscal Year 2020 ResultsOrthofix Reports Fourth Quarter and Fiscal Year 2020 Results
finance.yahoo.com - February 26 at 9:27 AM
Orthofix Medical earnings preview: what to expectOrthofix Medical earnings preview: what to expect
markets.businessinsider.com - February 24 at 3:20 PM
Trauma Implants Market growing at a CAGR of around 4.8% over the forecast period 2019 to 2026.Trauma Implants Market growing at a CAGR of around 4.8% over the forecast period 2019 to 2026.
marketwatch.com - February 24 at 10:18 AM
Trauma Products Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026Trauma Products Market Research Report by Manufacturers, Region, Type and Application, Forecast to 2026
marketwatch.com - February 22 at 7:57 PM
Spinal Thoracolumbar Implants Market Grow at a CAGR of 5.6% during 2018- 2027|Alphatec Holdings, Stryker Corporation, Globus Medical Inc.Spinal Thoracolumbar Implants Market Grow at a CAGR of 5.6% during 2018- 2027|Alphatec Holdings, Stryker Corporation, Globus Medical Inc.
marketwatch.com - February 22 at 2:57 PM
Medical Bionic Implants Market Size, Analysis Top Countries In-Depth Research, Trends, Emerging Growth Factors and Regional Forecasts to 2026Medical Bionic Implants Market Size, Analysis Top Countries In-Depth Research, Trends, Emerging Growth Factors and Regional Forecasts to 2026
marketwatch.com - February 17 at 1:22 AM
Spine Devices Market Size 2021 by Revenue Estimates, Capacity, Price, Gross Margin and Forecast to 2027 Research Report by Absolute ReportsSpine Devices Market Size 2021 by Revenue Estimates, Capacity, Price, Gross Margin and Forecast to 2027 Research Report by Absolute Reports
marketwatch.com - February 12 at 10:12 AM
DateCompanyBrokerageAction
3/31/2021AngioDynamicsCanaccord GenuityBoost Price Target
3/29/2021AngioDynamicsRaymond JamesReiterated Rating
10/4/2019AngioDynamicsKeyCorpLower Price Target
3/16/2021Intersect ENTSVB LeerinkBoost Price Target
1/15/2021Intersect ENTPiper SandlerBoost Price Target
11/19/2020Intersect ENTBTIG ResearchUpgrade
10/8/2020Intersect ENTJPMorgan Chase & Co.Downgrade
8/7/2020Intersect ENTGuggenheimUpgrade
8/4/2020Intersect ENTOppenheimerReiterated Rating
4/15/2020Intersect ENTBank of AmericaDowngrade
2/10/2021SurmodicsBarrington ResearchBoost Price Target
2/5/2021SurmodicsNeedham & Company LLCReiterated Rating
6/1/2020SurmodicsLake Street CapitalBoost Price Target
3/2/2021OraSure TechnologiesCitigroupLower Price Target
8/21/2020OraSure TechnologiesEvercore ISIInitiated Coverage
4/21/2020OraSure TechnologiesStephensInitiated Coverage
10/20/2020Orthofix MedicalStifel NicolausInitiated Coverage
2/25/2020Orthofix MedicalSidotiLower Price Target
2/25/2020Orthofix MedicalCantor FitzgeraldLower Price Target
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
Comparison Ideas:

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.